Lunit, an innovative company in the field of medical AI, has developed software that significantly contributes to the fight against cancer. Their technology, Lunit INSIGHT, boasts an impressive 97-99% accuracy rate in detecting anomalies in chest X-rays, some of which are undetectable to the human eye. This early detection is crucial in cancer treatment. Additionally, Lunit SCOPE leverages AI to predict treatment responses, aiding physicians in making more informed decisions for effective patient care. Lunit's AI solutions represent a significant leap in cancer diagnosis and treatment.
